Diadema Partners LP 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
Diadema Partners LP disclosed 46 US equity positions worth $160.8m in its Q2 2025 13F filing. The largest position was SLNOEUR at 14.8% of the reported book, followed by AMGN and TGTX. Against the Q1 2025 filing, it opened 17 new positions, added to 16 and reduced 11 among the top 46 holdings.
What did Diadema Partners LP own in Q2 2025? Top 46 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | SLNOEUR SOLENO THERAPEUTICS INC | 14.8% | $23.8m | 284,152 | 206% | added | |
| 2 | AMGN AMGEN INC | Healthcare | 9.0% | $14.5m | 52,100 | – | new |
| 3 | TGTX TG THERAPEUTICS INC | Healthcare | 8.3% | $13.4m | 371,448 | 79% | added |
| 4 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 7.3% | $11.8m | 94,042 | 51% | added |
| 5 | LLY ELI LILLY & CO | Healthcare | 7.2% | $11.5m | 14,816 | -23% | reduced |
| 6 | JAZZ JAZZ PHARMACEUTICALS PLC | Healthcare | 6.9% | $11.1m | 104,473 | 20% | added |
| 7 | BMRN BIOMARIN PHARMACEUTICAL INC | Healthcare | 6.6% | $10.6m | 192,877 | 265% | added |
| 8 | PCVX VAXCYTE INC | Healthcare | 4.0% | $6.4m | 198,285 | 115% | added |
| 9 | VKTX VIKING THERAPEUTICS INC | Healthcare | 3.3% | $5.2m | 197,468 | 90% | added |
| 10 | VRTX VERTEX PHARMACEUTICALS INC | Healthcare | 2.8% | $4.5m | 10,000 | – | new |
| 11 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 2.6% | $4.2m | 76,185 | – | new |
| 12 | GILD GILEAD SCIENCES INC | Healthcare | 2.1% | $3.3m | 30,000 | – | new |
| 13 | ARGX ARGENX SE | Healthcare | 2.0% | $3.3m | 5,974 | -51% | reduced |
| 14 | IMCR IMMUNOCORE HLDGS PLC | Healthcare | 2.0% | $3.3m | 104,384 | 8% | added |
| 15 | REGN REGENERON PHARMACEUTICALS | Healthcare | 1.8% | $2.9m | 5,607 | -81% | reduced |
| 16 | RVMD REVOLUTION MEDICINES INC | Healthcare | 1.8% | $2.9m | 79,079 | – | new |
| 17 | COGT COGENT BIOSCIENCES INC | Healthcare | 1.8% | $2.8m | 392,213 | 0% | held |
| 18 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 1.4% | $2.2m | 62,926 | 9% | added |
| 19 | 2662247D ITEOS THERAPEUTICS INC | 1.3% | $2.1m | 206,200 | – | new | |
| 20 | URGN UROGEN PHARMA LTD | Healthcare | 1.3% | $2.1m | 150,000 | 97% | added |
| 21 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 1.2% | $2.0m | 53,985 | – | new |
| 22 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 1.1% | $1.7m | 122,061 | -25% | reduced |
| 23 | MRK MERCK & CO INC | Healthcare | 1.0% | $1.6m | 20,000 | – | new |
| 24 | PCRX PACIRA BIOSCIENCES INC | Healthcare | 0.9% | $1.4m | 58,926 | 51% | added |
| 25 | OLMA OLEMA PHARMACEUTICALS INC | Healthcare | 0.7% | $1.1m | 253,657 | 154% | added |
| 26 | REVIVA PHARMACEUTCLS HLDGS I | 0.6% | $1.0m | 2,735,457 | 320% | added | |
| 27 | BRD1EUR MIND MEDICINE MINDMED INC | 0.6% | $1.0m | 158,536 | – | new | |
| 28 | TRVI TREVI THERAPEUTICS INC | Healthcare | 0.6% | $1.0m | 185,830 | 3% | added |
| 29 | 430 TERNS PHARMACEUTICALS INC | 0.6% | $969.2k | 259,852 | 363% | added | |
| 30 | ETNBGBP 89BIO INC | 0.6% | $966.1k | 98,382 | -57% | reduced | |
| 31 | CLYM CLIMB BIO INC | 0.5% | $870.6k | 702,135 | 5% | added | |
| 32 | SCPH SCPHARMACEUTICALS INC | 0.5% | $829.1k | 217,623 | – | new | |
| 33 | VTGN VISTAGEN THERAPEUTICS INC | 0.5% | $807.8k | 403,922 | -29% | reduced | |
| 34 | ARVN ARVINAS INC | Healthcare | 0.4% | $709.9k | 96,455 | – | new |
| 35 | APGE APOGEE THERAPEUTICS INC | Healthcare | 0.3% | $459.1k | 10,572 | -74% | reduced |
| 36 | PHAT PHATHOM PHARMACEUTICALS INC | 0.2% | $386.4k | 40,294 | – | new | |
| 37 | NUVALENT INC | 0.2% | $381.5k | 5,000 | – | new | |
| 38 | ALEC ALECTOR INC | Healthcare | 0.2% | $372.4k | 266,023 | -42% | reduced |
| 39 | PROQR THRAPEUTICS N V | 0.2% | $321.7k | 157,694 | -24% | reduced | |
| 40 | REPL REPLIMUNE GROUP INC | Healthcare | 0.2% | $301.8k | 32,483 | -56% | reduced |
| 41 | ELDN ELEDON PHARMACEUTICALS INC | 0.1% | $175.1k | 64,613 | 0% | held | |
| 42 | RLAY RELAY THERAPEUTICS INC | Healthcare | 0.1% | $150.9k | 43,616 | -90% | reduced |
| 43 | ELEVATION ONCOLOGY INC | 0.1% | $133.2k | 362,935 | – | new | |
| 44 | PURETECH HEALTH PLC | 0.1% | $126.3k | 7,324 | – | new | |
| 45 | SMMT SUMMIT THERAPEUTICS INC | Healthcare | 0.0% | $19.8k | 932 | – | new |
| 46 | ZLAB ZAI LAB LTD | Healthcare | 0.0% | $13.2k | 3,785 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.